Daljit Singh Aurora - 17 Feb 2026 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
Title: Chief Operating and Development Officer
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Daljit Singh Aurora
Issuer symbol
NMRA
Transactions as of
17 Feb 2026
Net transactions value
-$21,917
Form type
4
Filing time
19 Feb 2026, 17:07:13 UTC
Previous filing
09 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Aurora Daljit Singh Title: Chief Operating and Development Officer C/O NEUMORA THERAPEUTICS, INC., 260 ARSENAL WAY, SUITE 1, WATERTOWN /s/ Michael Milligan, as Attorney-in-Fact for Daljit Singh Aurora 19 Feb 2026 0001793971

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Sale $21,917 -6,165 -6.9% $3.56 82,770 17 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

Title: Chief Operating and Development Officer